Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	-88.94	-45.14	408.13
Graham Fair Price	789.59	0.61	0.07
PEG	96.74	-0.05	-1.39
Price/Book	55.48	-19.26	-43.27
Price/Cash Flow	98.35	489.74	246.90
Prices/Earnings	-93.59	-9.09	141.88
Price/Sales	65.80	32.79	19.78
Price/FCF	98.35	489.74	246.90
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	-20.18	0.53	0.66
Operating Margin	-29.66	-0.04	0.05
ROA	2428.61	-0.08	< 0.005
ROE	-0.08	0.53	594.96
ROIC	< 0.005	< 0.005	-14.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.03	< 0.005	-494.67
Dividends QOQ	-0.71	-1.00	-41.35
EBIT QOQ	1.03	0.87	-15.80
EPS QOQ	1.02	-2.01	96.71
FCF QOQ	2.08	-0.19	-91.01
Revenue QOQ	-0.02	-0.10	-327.90
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	169.20	111.67	-34.00
Days Sales Outstanding (DSO)	87.54	98.97	13.05
Inventory Turnover	0.53	0.81	51.51
Debt/Capitalization	1.08	1.38	27.07
Quick Ratio	-0.21	0.14	-31.34
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	-0.05	-0.30	-464.22
Cash	-0.37	0.02	-93.34
Capex	< 0.005	< 0.005	-41.14
Free Cash Flow	< 0.005	< 0.005	-24.27
Revenue	0.11	0.10	-9.40
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	0.24	0.20	-18.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	128.51	-6.95	-94.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating